3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Income investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49% over the next 12 months, according to Wall Street.
(NYSE: PFE) stock has been on a downward trajectory for nearly two and a half years. Blame it mainly on declining demand for the company's COVID-19 vaccine and oral antiviral drug Paxlovid. However, Pfizer also faces the looming loss of exclusivity for multiple products.
Despite this bad news, analysts remain perhaps surprisingly bullish about Pfizer. The average analysts' 12-month price target reflects an upside potential of around 22%. Not everyone on Wall Street is enamored with Pfizer. One analyst surveyed by LSEG in April recommended selling the stock. But over half of the analysts polled rated Pfizer as a buy or a strong buy.
Source Fool.com
Pfizer Inc. Aktie
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.73 € bedeuten.
